MICHELLE CLARK: Open Payments
NPI 1881226462 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 35 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $915
Food & beverage: $815Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $172 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $82 |
| Daiichi Sankyo Inc. | 2 | $53 |
| SpringWorks Therapeutics, Inc. | 2 | $52 |
| Janssen Biotech, Inc. | 2 | $48 |
| Adaptive Biotechnologies Corporation | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Genentech USA, Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $35 |
Products named: Nubeqa, Enhertu, JAKAFI, KISQALI, TECVAYLI, clonoSEQ, KEYTRUDA, GOMEKLI.
Industry payments across NY — which companies pay providers there.
